Dr. Hönle AG

Equities

HNL

DE0005157101

Industrial Machinery & Equipment

Market Closed - Xetra Other stock markets 09:06:02 13/05/2024 pm IST			5-day change	1st Jan Change
19.5 ^EUR	0.00%		-2.99%	+11.43%

08/05	Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
26/02	Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Dr. Hönle AG Provides Earnings Guidance for the Financial Year 2021/2022

February 18, 2022 at 02:10 pm IST

Dr. Hönle AG provided earnings guidance for the financial year 2021/2022. The Management Board expects revenues of between EUR 130 million and EUR 140 million and an operating result (EBIT) of between EUR 14 million and EUR 17 million in financial year 2021/2022.

Latest news about Dr. Hönle AG

Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	08/05	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	26/02	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023	25/01	CI
Dr. Hönle Ag Provides Earnings Guidance for the Year 2022/2023 and 2023/2024	06/12	CI
Dr. Hönle AG Announces Management Changes	20/23/20	CI
Dr. Hönle AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	08/23/08	CI
Dr. Hönle Ag Provides Earnings Guidance for the Year 2023	07/23/07	CI
Dr. Hönle AG Revises Earnings Guidance for the Year 2022/ 2023	02/23/02	CI
Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	13/23/13	CI
Dr. Hönle AG Announces Executive Changes	26/23/26	CI
Dr. Hönle AG Announces Board Changes	31/23/31	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2022	24/23/24	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2022	30/23/30	CI
Dr. Hönle AG Announces Planned Change in Supervisory Board	15/22/15	CI
An unknown buyer acquired Raesch Quarz GmbH from Dr. Hönle AG.	12/22/12	CI
Dr. Hönle AG Revises Earnings Guidance for the Year 2021/2022	02/22/02	CI
Dr. Hönle AG(XTRA:HNL) dropped from S&P Global BMI Index	19/22/19	CI
Norbert Haimerl Becomes CEO of Dr. Hönle AG	23/22/23	CI
Dr. Hönle AG Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	06/22/06	CI
Dr. Hönle AG Provides Earnings Guidance for 2022	29/22/29	CI
Dr. Hönle AG Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	12/22/12	CI
Dr. Hönle Ag Provides Earnings Guidance for 2022	12/22/12	CI
Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2021	22/22/22	CI
Dr. Hönle AG Provides Earnings Guidance for the Financial Year 2021/2022	18/22/18	CI
Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2021	27/22/27	CI

Chart Dr. Hönle AG

Duration

Period

More charts

Company Profile

Dr Hoenle AG is a Germany-based company engaged in the basic materials and industrials sectors. The Company develops, manufactures and supplies ultraviolet (UV) equipment. The Company operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The Company is globally active, with over 69 locations in 27 countries.

Sector

Industrial Machinery & Equipment

Calendar

07/08/2024 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Dr. Hönle AG

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.5 EUR

Average target price

28.15 EUR

Spread / Average Target

+44.36%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Industrial Machinery & Equipment

	1st Jan change	Capi.
DR. HÖNLE AG	+11.43%	127M
ATLAS COPCO AB	+15.13%	87.2B
PARKER-HANNIFIN CORPORATION	+19.61%	72.13B
INGERSOLL RAND INC.	+17.46%	36.82B
XYLEM INC.	+23.53%	34.67B
FANUC CORPORATION	+11.38%	28.34B
FORTIVE CORPORATION	+4.35%	27.06B
SANDVIK AB	+6.60%	26.98B
TECHTRONIC INDUSTRIES CO. LTD.	+22.73%	26.3B
DOVER CORPORATION	+19.80%	25.5B

Other Industrial Machinery & Equipment